Related Experiment Video

Updated: Jul 14, 2026

Real-Time Dynamic Collection of Hippocampal Extracellular Fluid from Conscious Rats Using a Microdialysis System
05:43

Real-Time Dynamic Collection of Hippocampal Extracellular Fluid from Conscious Rats Using a Microdialysis System

Published on: October 21, 2022

Minimal hepatic encephalopathy: simplifying its diagnosis

Satish Iduru, Kola Hisamuddin, Kevin D Mullen

    The American Journal of Gastroenterology
    |June 27, 2007
    PubMed

    Insights

    Minimal hepatic encephalopathy (MHE), a common cirrhosis complication affecting quality of life, can be diagnosed using inhibitory control testing (ICT). This reliable screening tool is easily administered, showing potential for widespread clinical use.

    Area of Science:

    • Hepatology
    • Neurology
    • Clinical Diagnostics

    Background:

    • Minimal hepatic encephalopathy (MHE) significantly impacts the quality of life for patients with cirrhosis.
    • Clinical diagnosis of MHE is often challenging due to subtle symptoms.
    • Inhibitory control testing (ICT) is an established screening method for MHE.

    Discussion:

    • The study validates ICT as a simple, reliable screening tool for MHE.
    • ICT can be effectively administered by ancillary clinical staff.
    • The findings suggest ICT's potential for widespread adoption in diagnosing MHE.

    Key Insights:

    • Inhibitory control testing (ICT) demonstrates high reliability and ease of use for MHE screening.
    • Ancillary staff can be trained to administer ICT, improving clinic efficiency.
    • ICT shows promise as a popular diagnostic tool for MHE in cirrhosis patients.

    Outlook:

    • Further multicenter studies are recommended to validate ICT for broader clinical application.
    • Wider validation could establish ICT as a standard diagnostic tool for all cirrhosis patients.
    • The integration of ICT into routine clinical practice could improve MHE detection rates.

    More Related Videos

    The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury07:27

    The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

    Published on: October 21, 2017

    Related Concept Videos

    Hepatic Encephalopathy01:29

    Hepatic Encephalopathy

    DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

    In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

    Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...